Related Experiment Videos
Expression of stem cell factor by osteoblasts in normal and hyperparathyroid bone: relation to ectopic mast cell
H C Blair1, S S Dong, B A Julian
1Veterans' Affairs Medical Center and Department of Pathology, University of Alabama School of Medicine, Birmingham 35294-0007, USA. Blair@path.uab.edu
Virchows Archiv : an International Journal of Pathology
|August 4, 1999
Summary
Hyperparathyroidism increases osteoblast production of stem cell factor (SCF), a growth factor that drives mast cell differentiation. This suggests osteoblastic SCF likely causes mast cell accumulation in hyperparathyroid bone.
Area of Science:
- Bone biology
- Cellular and molecular medicine
- Endocrinology
Background:
- Mast cells are found in hyperparathyroid bone, but their role and origin are unclear.
- The relationship between mast cells and bone-remodeling cells in hyperparathyroidism requires further investigation.
Purpose of the Study:
- To compare mast cell distribution and associated growth factors in normal versus hyperparathyroid bone.
- To elucidate the role of osteoblast-derived factors in mast cell accumulation during hyperparathyroidism.
Main Methods:
- Immunohistochemical analysis of mast cells and stem cell factor (SCF) in normal and hyperparathyroid bone samples.
- Comparison of SCF production by active osteoblasts versus quiescent osteoblasts.
- Analysis of SCF isoforms in osteoblast-derived cells.
Main Results:
- Mast cell accumulation in hyperparathyroid bone is associated with proximity to bone-forming surfaces.
- Hyperparathyroidism significantly elevates osteoblast production of SCF, but not IL-3.
- Osteoblast-derived SCF is localized to cell membranes and likely drives mast cell differentiation.
Conclusions:
- Increased osteoblastic stem cell factor (SCF) production in hyperparathyroidism is the probable driver of mast cell accumulation.
- While mast cells are not typical bone components, their differentiation may be a side effect of heightened osteoblastic activity and SCF signaling.